The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
出版年份 2022 全文链接
标题
The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
作者
关键词
Liver transplantation, Hepatocellular carcinoma, Prognosis, Adjuvant targeted therapy, Predicting
出版物
Hepatobiliary & Pancreatic Diseases International
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-04-26
DOI
10.1016/j.hbpd.2022.04.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria
- (2020) Ani Kardashian et al. HEPATOLOGY
- Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma
- (2019) Ping Sun et al. MEDICINE
- Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
- (2019) Ka Wing Ma et al. World Journal of Gastrointestinal Oncology
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- EXPERIENCE WITH EARLY SORAFENIB TREATMENT WITH mTOR INHIBITORS IN HEPATOCELLULAR CARCINOMA RECURRING AFTER LIVER TRANSPLANTATION
- (2019) Federica Invernizzi et al. TRANSPLANTATION
- Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation
- (2018) Nan Jiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
- (2018) Cheng-Qian Zhong et al. Cancer Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany
- (2018) Zhi Qu et al. LANGENBECKS ARCHIVES OF SURGERY
- New Systemic Treatments in Advanced Hepatocellular Carcinoma
- (2018) Marco Sanduzzi-Zamparelli et al. LIVER TRANSPLANTATION
- Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
- (2017) Laura Kulik et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
- (2017) Gonzalo Sapisochin et al. Nature Reviews Gastroenterology & Hepatology
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
- (2017) Neil Mehta et al. JAMA Oncology
- The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
- (2016) Michał Grąt et al. ANNALS OF SURGICAL ONCOLOGY
- Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
- (2016) Yan Lu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
- (2016) Wen-Ming Cong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival
- (2015) Shunji Nagai et al. CLINICAL TRANSPLANTATION
- Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients
- (2015) Arno Kornberg et al. DIGESTIVE DISEASES AND SCIENCES
- Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
- (2015) Xiao Xu et al. GUT
- A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function
- (2015) Yang Li et al. Hepatobiliary & Pancreatic Diseases International
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation
- (2015) Shunji Nagai et al. HEPATOLOGY
- A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
- (2015) Vatche G. Agopian et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta-analysis
- (2014) Zhouying Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria
- (2014) Bilal Hameed et al. LIVER TRANSPLANTATION
- The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
- (2014) Jun Chen et al. PLoS One
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
- (2013) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?
- (2013) Gerd Otto et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
- (2011) Shaheed Merani et al. JOURNAL OF HEPATOLOGY
- Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
- (2011) Thomas Decaens et al. LIVER INTERNATIONAL
- Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation
- (2011) Vivek Kohli et al. TRANSPLANT INTERNATIONAL
- Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells
- (2009) Alessandro Corti et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences
- (2009) Shu-Sen Zheng et al. TRANSPLANTATION
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started